Question:
As compared with clopidogrel (Plavix), ticagrelor (Brilinta) reduces the risk of cardiovascular events in acute coronary syndrome patients undergoing percutaneous coronary intervention, but at the expense of higher bleeding rates.
Format:
Radio buttons (single select)
